Sandbox Cardiovascular Drugs2/Vasodilators: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
! style="font-size: 99%; padding: 0 5px; background: #104E8B;" | [[Sandbox Cardiovascular Drugs2|{{Fontcolor|#F8F8FF|Cardiovascular Drugs}}]] | ! style="font-size: 99%; padding: 0 5px; background: #104E8B;" | [[Sandbox Cardiovascular Drugs2|{{Fontcolor|#F8F8FF|Cardiovascular Drugs}}]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antiarrhythmics|{{Fontcolor|#F8F8FF|Antiarrhythmics}}]] | ! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antiarrhythmics|{{Fontcolor|#F8F8FF|Antiarrhythmics}}]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antihypertensives|{{Fontcolor|#F8F8FF|Antihypertensives}}]] | ! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antihypertensives|{{Fontcolor|#F8F8FF|Antihypertensives}}]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antithrombotics|{{Fontcolor|#F8F8FF|Antithrombotics}}]] | ! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antithrombotics|{{Fontcolor|#F8F8FF|Antithrombotics}}]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Beta Blockers|{{Fontcolor|#F8F8FF|Beta Blockers}}]] | ! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Beta Blockers|{{Fontcolor|#F8F8FF|Beta Blockers}}]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Calcium Channel Blockers|{{Fontcolor|#F8F8FF|Calcium Channel Blockers}}]] | ! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Calcium Channel Blockers|{{Fontcolor|#F8F8FF|Calcium Channel Blockers}}]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Cardiac Stimulants|{{Fontcolor|#F8F8FF|Cardiac Stimulants}}]] | ! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Cardiac Stimulants|{{Fontcolor|#F8F8FF|Cardiac Stimulants}}]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Diuretics|{{Fontcolor|#F8F8FF|Diuretics}}]] | ! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Diuretics|{{Fontcolor|#F8F8FF|Diuretics}}]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Lipid-Modifying Agents|{{Fontcolor|#F8F8FF|Lipid-Modifying Agents}}]] | ! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Lipid-Modifying Agents|{{Fontcolor|#F8F8FF|Lipid-Modifying Agents}}]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Renin-Angiotensin System Inhibitors|{{Fontcolor|#F8F8FF|Renin-Angiotensin System Inhibitors}}]] | ! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Renin-Angiotensin System Inhibitors|{{Fontcolor|#F8F8FF|Renin-Angiotensin System Inhibitors}}]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 0 10px #F0F8FF;" align=left |[[Sandbox Cardiovascular Drugs2/Vasodilators|{{Fontcolor|#F8F8FF|Vasodilators}}]] | ! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 0 10px #F0F8FF;" align=left |[[Sandbox Cardiovascular Drugs2/Vasodilators|{{Fontcolor|#F8F8FF|Vasodilators}}]] | ||
|} | |} | ||